The 26 references in paper B. Chernyak A., I. Trofimenko N., Б. Черняк А., И. Трофименко Н. (2014) “Влияние терапии тиотропием на бронхиальную гиперреактивность и клинико-функциональные показатели у больных хронической обструктивной болезнью легких // Effect of tiotropium on bronchial hyperreactivity and clinical and functional parameters in patients with chronic obstructive pulmonary disease” / spz:neicon:pulmonology:y:2012:i:2:p:46-51

1
Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma. UPDATED 2011. www.ginasthma.org
(check this in PDF content)
2
Barnes P.J.Mechanisms in COPD. Differences from asthma. Chest 2000; 117: 10–14.
(check this in PDF content)
3
Kanner R.E., Connett J.E., Altose M.D. et al.Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am. J. Respir. Crit. Care Med. 1994; 150 (4): 956–961.
(check this in PDF content)
4
Yang S.C., Lin B.Y.Comparison of airway hyperreactivity in chronic obstructive pulmonary disease and asthma. Chang Gung Med. J. 2010; 33: 515–523.
(check this in PDF content)
5
Трофименко И.Н., Черняк Б.А. Бронхиальная гиперреактивность как фенотипическая характеристика хронической обструктивной болезни легких. Пульмонология 2011; 4: 49–53.
(check this in PDF content)
6
Brutsche M.H., Downs S.H., Schindler C. et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Thorax 2006; 61: 671–677.
(check this in PDF content)
7
Xu X., Rijcken B., Schouten J.P. et al.Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 1997; 350: 1431–1434.
(check this in PDF content)
8
Marco R., Accordini S., Marcon A. et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am. J. Respir. Crit. Care Med. 2011; 183 (7): 891–897.
(check this in PDF content)
9
Tashkin D.P., Altose M.D., Connett J.E. et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am. J. Respir. Crit. Care Med. 1996; 153: 1802–1811.
(check this in PDF content)
10
Hospers J.J., Postma D.S., Rijcken B. et al. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000; 356: 1313–1317.
(check this in PDF content)
11
Grootendorst D.C., Rabe K.F.Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2004; 1: 77–87.
(check this in PDF content)
12
Wise R.A., Kanner R.E., Lindgren P. et al.The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study. Chest 2003; 124: 449–458.
(check this in PDF content)
13
Postma D.S., Kerstjens H.A.M.Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 158: 187–192. Черняк Б.А., Трофименко И.Н.Влияние терапии тиотропием на бронхиальную гиперреактивность
(check this in PDF content)
14
Lancas T., Kasahara D.I., Gross J.L. et al.Cholinergic hyperresponsiveness of peripheral lung parenchyma in chronic obstructive pulmonary disease. Respiration 2011; 82: 177–184.
(check this in PDF content)
15
Fisher J.T., Vincent S.G., Gomeza J. et al.Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors. FASEB J. 2004; 18 (6): 711–713.
(check this in PDF content)
16
Belmonte K.E.Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005; 2: 297–304.
(check this in PDF content)
17
O'Connor B.J., Towse L.J., Barnes P.J. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am. J. Respir. Crit. Care Med. 1996; 154: 876–880.
(check this in PDF content)
18
Gosens R., Zaagsma J., Meurs H. et al.Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir. Res. 2006; 7 (1): 73.
(check this in PDF content)
19
Cao R., Dong X.W., Jiang J.X. et al. M (3) muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice. Eur. J. Pharmacol. 2011; 655: 83–90.
(check this in PDF content)
20
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011.www.goldcopd.org
(check this in PDF content)
21
Gulsvik A., Refvem O.K.Ascoring system on respiratory symptoms. Eur. Respir. J. 1988; 1: 428–432.
(check this in PDF content)
22
Чучалин А.Г.(ред.). Пульмонология. Клинические рекомендации. М.: ГЭОТАР-Медиа; 2005. 212–213.
(check this in PDF content)
23
Klein G., Köhler D., Bauer C.P. et al.Standartization of inhalation chal-lenges for measuring the unspecific bronchial inhalation challenge by re-servuar-method. Pneumologie 1991; 45: 60–64.
(check this in PDF content)
24
Стандартизация легочных функциональных тестов: Пер. с англ. под ред. А.Г.Чучалина. М.; 1993. 68–69.
(check this in PDF content)
25
Troosters T., Celli B., Lystig T. et al. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT® trial. Eur. Respir. J. 2010; 36 (1): 65–73.
(check this in PDF content)
26
Selivanova P.A., Kulikov E.S., Kozina O.V. et al. Differential expression of the β2-adrenoreceptor and M3-cholinoreceptor genes in bronchial mucosa of patients with asthma and chronic obstructive pulmonary disease. Ann. Allergy Asthma Immunol. 2012; 108: 39–43.
(check this in PDF content)